More Articles

First generic celecoxib approved by FDA Generics/News | Posted 13/06/2014

The US Food and Drug Administration (FDA) announced on 30 May 2014 that it had approved the first generic versions of celecoxib capsules.

Impact of price cuts on spending on hyperlipidaemic drugs in South Korea Generics/Research | Posted 06/06/2014

Rapidly increasing pharmaceutical expenditures have become a constant challenge to the sustainability of healthcare systems across countries including Korea.

Top 8 blockbuster biologicals 2013 Biosimilars/General | Posted 06/06/2014

The top three best-selling drugs during 2013 were biologicals. All three best-sellers are indicated for the treatment of arthritis, and include Abbott’s Humira (adalimumab), Merck’s Remicade (infli...

Europe–Japan cooperation on generics and biosimilars regulation Policies & Legislation | Posted 06/06/2014

Japanese and European generics groups have met to discuss increase regulatory cooperation between the two regions.

Brazil speeds up approval process for generics and biologicals Guidelines | Posted 06/06/2014

Brazil’s National Health Surveillance Agency [Agência Nacional de Vigilância Sanitária, ANVISA] announced on 3 June 2014 the publication of a new guideline for generics and biologicals aimed at spe...

Abbott expands generics business in Latin America Pharma News | Posted 06/06/2014

US-based pharma company Abbott Laboratories (Abbott) announced on 16 May 2014 that it was expanding its presence in Latin American and increasing its branded generics portfolio with the acquisition...

US will continue to buy Indian generics despite quality concerns Reports | Posted 06/06/2014

According to a recent report by India’s most respected rating agency the high number of import alerts issued by the US Food and Drug Administration (FDA) in 2013 will have no impact on the existing...

Biosimilars developer Coherus raises US$55 million investment Biosimilars/News | Posted 06/06/2014

US-based biosimilars developer Coherus BioSciences (Coherus) announced on 19 May 2014 that it had raised investments of US$55 million. New investors KKR & Co LP, Venrock, RA Capital Management,...